Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Synchrony Financial: Strong Q2 Results Drive Continued Earnings Strength
- Sherwin-Williams (SHW) Q2 2025 Earnings Report: Sales Beat Estimates, But Full-Year Outlook Slashed
- Red Cat Holdings, Inc. Faces Multiple Class Action Lawsuits from Investors
- Organon & Co. Investors: Important Deadline Alerts and Class Action Lawsuits
- Northrop Grumman Soars 3% After Strong Q2 Earnings Report
- Netflix and Amazon Stock Analysis
- European Visibility Boost for Glenstar Minerals as they Begin Trading on Tradegate Exchange
- Stock Market Today: Lucid and OpenDoor Surge, Momentum Stocks Fluctuate
- Invesco Ltd. (IVZ) Q2 2025 Earnings Conference Report
- Interpublic Group Posts Strong Q2 Results, Launches Agentic Systems for Commerce
- Fortrea Holdings Inc. Investors Urged to Seek Legal Counsel Amid Lawsuits and Share Price Collapse
- Boeing Updates: Contract Offer Sent to Union Members, 777-8 Freighter Production Begins, and Global Demand Forecast Released
- Verizon's Strong Q2 Results Point to Positive Future Outlook
- Homebuilder Stocks Surge on Strong Earnings Reports
- Potential Lead Opportunity for NEOG Investors in Securities Fraud Lawsuit
- Danaher Raises 2025 Earnings Outlook
- Gold Takes the Spotlight: Market Trends and Breakthrough Technologies
- Kohl's and Opendoor Spark Meme Stock Frenzy on Social Media
- Palantir Technologies Inc. (PLTR) Stock Analysis: A Comprehensive Look at the Latest Trends
- Centene Corporation Class Action Lawsuit Update
- Quest Diagnostics Reports Strong Q2 2025 Results, Raises Full-Year Guidance
- RTX Vs. Lockheed: A Fighter Jet Showdown
- Texas Instruments (TXN) Reports Strong Q2 Results, Stock Falls on Weak Forecast
- Class Action Lawsuit Filed Against Alto Neuroscience, Inc. (ANRO)
- Intuitive Surgical (ISRG) Q2 Earnings Report Analysis
- Deadline Approaching in Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
- Lawsuit Filed Against Sarepta Therapeutics for Securities Law Violations
- Analyzing the Magnificent 7 Stock Rankings: Nvidia Reigns Supreme
- AstraZeneca Commits $50 Billion to US Expansion Amid Tariff Pressures
- Oracle (ORCL) Stock News: OpenAI Deal Leads to Data Center Expansion
- Kohl's and Opendoor Lead Surge of Meme Stocks in Market Frenzy
- Quarterly Report on Various Bancorps' Financial Performance
- The Rise of A.I.: Google's DeepMind Beats Teenagers at Math Olympiad and Alphabet's Earnings Preview
- Amazon's Acquisition of Bee and Stock Rally Analysis
- Analyzing the Magnificent 7: Top Stock Ranking and Recent Apple Developments
- Nvidia Stock News: S&P 500 Record Close, OpenDoor And Navitas Lead Momentum Stocks
- Philip Morris International Inc. (PM) Q2 2025 Earnings Performance and Market Response
- Tesla's Historical Performance Post Earnings
- Lockheed Martin Faces Setback with Q2 Earnings, Focused on Future Growth
- President Trump's Request Fulfilled: Coca-Cola to Launch Cane Sugar-Sweetened Drink
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with